On July 21, 2026, Chairman Gabriele Cerrone increased his stake in OKYO Pharma Ltd through Panetta Partners Ltd by purchasing 25,000 ordinary shares at $1.40 per share. This transaction brings his total holding to 10,851,416 ordinary shares, representing 20.51% of the company's issued share capital. OKYO Pharma is a clinical-stage biopharmaceutical company developing therapies for neuropathic corneal pain and anterior segment eye diseases.
